Written question asked by Kevin Barron (Labour) on Tuesday, 12 February 2019, in the House of Commons. It was due for an answer on Monday, 18 February 2019 (named day). It was answered by Steve Brine (Conservative) on Monday, 18 February 2019 on behalf of the Department of Health and Social Care.
NHS: Finance
- Question
-
To ask the Secretary of State for Health and Social Care, how has the £300 million per year to fund new diagnostic equipment and additional staff capacity announced in the 2015 Comprehensive Spending Review has been allocated.
- Answer
-
The 2015 Comprehensive Spending Review made a commitment to invest up to £300 million per year by 2020/21. The published financial profile agreed for the NHS England Cancer Programme over the four years to 2020/21 was:
2017/18
2018/19
2019/20
2020/21
£123 million
£140 million
£154 million
£190 million
This is being invested in earlier diagnosis and personalised care, including additional staff capacity and equipment. In addition, £130 million has been invested to modernise radiotherapy equipment. Funding has been allocated for over 80 new or upgraded linear accelerators across the country since October 2016.
Secondary information
- Type
- Written question
- Reference
- 220081
- Session
- 2017-19
- Subjects
- Finance NHS Staff Medical equipment
- Contains statistics
- Yes
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-02-18 18:21:48 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/220081
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/220081
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/220081